Good news: Johnson and Johnson’s vaccine candidate’s preliminary results look good

The new clinical trial data shows a single shot of the vaccine “gives sustainable antibodies,” Dr. Paul Stoffels, J&J chief scientific officer, told CNBC.

Source: J&J’s one-shot Covid vaccine is safe, generates promising immune response

This vaccine may be shipping by April, and if the U.S. has an order for this vaccine, this might provide sufficient doses to vaccinate a large number and ensure that vaccinations are open to the general public before summer.